ATE517917T1 - Herstellung eines rekombinanten il-18-bindenden proteins - Google Patents

Herstellung eines rekombinanten il-18-bindenden proteins

Info

Publication number
ATE517917T1
ATE517917T1 AT06763472T AT06763472T ATE517917T1 AT E517917 T1 ATE517917 T1 AT E517917T1 AT 06763472 T AT06763472 T AT 06763472T AT 06763472 T AT06763472 T AT 06763472T AT E517917 T1 ATE517917 T1 AT E517917T1
Authority
AT
Austria
Prior art keywords
binding protein
recombinant
preparation
composition
production
Prior art date
Application number
AT06763472T
Other languages
English (en)
Inventor
Urs Weber
Thierry Ziegler
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Application granted granted Critical
Publication of ATE517917T1 publication Critical patent/ATE517917T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT06763472T 2005-06-03 2006-06-01 Herstellung eines rekombinanten il-18-bindenden proteins ATE517917T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US68763105P 2005-06-03 2005-06-03
EP05104878 2005-06-03
EP05106429 2005-07-13
PCT/EP2006/062851 WO2006128908A1 (en) 2005-06-03 2006-06-01 Production of recombinant il-18 binding protein
EP06763472A EP1885753B1 (de) 2005-06-03 2006-06-01 Herstellung eines rekombinanten Il-18-bindenden Proteins

Publications (1)

Publication Number Publication Date
ATE517917T1 true ATE517917T1 (de) 2011-08-15

Family

ID=44352415

Family Applications (2)

Application Number Title Priority Date Filing Date
AT10184728T ATE557038T1 (de) 2005-06-03 2006-06-01 Herstellung von rekombinantem il-18 bindendem protein
AT06763472T ATE517917T1 (de) 2005-06-03 2006-06-01 Herstellung eines rekombinanten il-18-bindenden proteins

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT10184728T ATE557038T1 (de) 2005-06-03 2006-06-01 Herstellung von rekombinantem il-18 bindendem protein

Country Status (15)

Country Link
US (2) US7691611B2 (de)
EP (2) EP1885753B1 (de)
JP (2) JP5199073B2 (de)
AT (2) ATE557038T1 (de)
AU (1) AU2006254103B2 (de)
CA (1) CA2609060C (de)
CY (2) CY1111969T1 (de)
DK (2) DK1885753T3 (de)
ES (2) ES2370417T3 (de)
IL (1) IL187838A (de)
NO (1) NO342802B1 (de)
PL (2) PL2267024T3 (de)
PT (2) PT2267024E (de)
SI (2) SI1885753T1 (de)
WO (1) WO2006128908A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058956A2 (en) * 2000-02-10 2001-08-16 Abbott Laboratories Antibodies that bind human interleukin-18 and methods of making and using
ES2309508T3 (es) 2003-03-11 2008-12-16 Laboratoires Serono Sa Vectores de expresion que comprenden el promotor de mcmv-ie2.
PT1622939E (pt) * 2003-05-13 2012-03-28 Merck Serono Sa Variantes ativas da proteína de ligação à il-18 e suas utilizações médicas
CA2541523A1 (en) 2003-10-21 2005-05-06 Applied Research Systems Ars Holding N.V. Minimal dna sequence acting as a chromatin insulator and its use in protein expression
ME01198B (me) * 2003-11-05 2013-03-20 Ares Trading Sa Prečišćavanje il-18 vezujućeg proteina
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
AU2005217154B2 (en) 2004-03-01 2010-02-18 Ares Trading S.A. Use of a serum-free cell culture medium for the production of IL-18BP in mammalian cells
AU2005259269B2 (en) * 2004-06-29 2010-12-09 Ares Trading S.A. Process for the purification of IL-18 binding protein
RS52273B (en) 2005-06-10 2012-10-31 Ares Trading S.A. PROCESS FOR PURIFICATION OF IL-18 BINDING PROTEIN
US20160145589A1 (en) 2011-06-24 2016-05-26 Green Cross Corporation Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
CA2952347A1 (en) 2011-07-01 2013-01-10 Amgen Inc. Mammalian cell culture
US9150841B2 (en) 2012-06-29 2015-10-06 Shire Human Genetic Therapies, Inc. Cells for producing recombinant iduronate-2-sulfatase
KR101380740B1 (ko) 2012-06-29 2014-04-11 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 이듀로네이트-2-설파타제의 정제
US20140004097A1 (en) * 2012-06-29 2014-01-02 Shire Human Genetic Therapies, Inc. Method of producing recombinant iduronate-2-sulfatase
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
US9677105B2 (en) * 2013-03-14 2017-06-13 Momenta Pharmaceuticals, Inc. Methods of cell culture
US8956830B2 (en) 2013-03-14 2015-02-17 Momenta Pharmaceuticals, Inc. Methods of cell culture
JP6689189B2 (ja) 2013-03-26 2020-04-28 コヒラス・バイオサイエンシズ・インコーポレイテッド タンパク質産生方法
WO2015032932A1 (en) 2013-09-05 2015-03-12 Ab2 Bio Sa Il-18 binding protein (il-18bp) in inflammatory diseases
USD759075S1 (en) * 2014-04-11 2016-06-14 Nutonian, Inc. Display screen with graphical user interface
USD759076S1 (en) * 2014-04-18 2016-06-14 Nutonian, Inc. Display screen with graphical user interface
MX2017010919A (es) 2015-03-05 2017-12-07 Ab2 Bio Sa Proteina de union il-18 (il-18bp) y anticuerpos en enfermedades inflamatorias.
KR101789509B1 (ko) * 2015-11-05 2017-10-26 주식회사 프로젠 재조합 인간 갑상선 자극 호르몬을 포함하는 조성물 및 상기 재조합 인간 갑상선 자극 호르몬의 생산 방법
EA202090740A1 (ru) 2017-10-16 2020-07-07 Ридженерон Фармасьютикалз, Инк. Перфузионный биореактор и связанные с ним способы применения

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4588585A (en) 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US5116943A (en) 1985-01-18 1992-05-26 Cetus Corporation Oxidation-resistant muteins of Il-2 and other protein
US5266476A (en) 1985-06-18 1993-11-30 Yeda Research & Development Co., Ltd. Fibrous matrix for in vitro cell cultivation
US5017691A (en) 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
US4879111A (en) 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4904584A (en) 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
JP2864434B2 (ja) 1991-01-18 1999-03-03 サイナーゲン，インコーポレーテッド 腫瘍壊死因子媒介疾患の治療方法
JP4306813B2 (ja) * 1995-09-19 2009-08-05 アスビオファーマ株式会社 動物細胞の新規培養方法
NZ331539A (en) 1996-02-20 2000-01-28 Applied Research Systems Hybrid proteins from two coexpressed receptors to form a heterodimer
NZ333325A (en) 1996-07-12 2000-06-23 Genentech Inc Recombinant chimeric heteromultimer adhesins comprising extracellular domains of ErbB receptors
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
CA2377513A1 (en) 1999-06-25 2001-01-04 Universitat Zurich Hetero-associating coiled-coil peptides
JP4944324B2 (ja) 1999-07-13 2012-05-30 ボルダー バイオテクノロジー， インコーポレイテッド 免疫グロブリン融合タンパク質
IL131047A0 (en) 1999-07-22 2001-01-28 Yeda Res & Dev Use of il-18 inhibitors
UA74557C2 (en) * 1999-09-03 2006-01-16 Applied Research Systems A method for producing a heterologous secreted protein from chinese hamster ovaries cells grown on microcarriers
CN1322897C (zh) 2000-02-21 2007-06-27 应用研究系统Ars股份公司 Il－18抑制剂的应用
HU229375B1 (en) 2000-05-05 2013-11-28 Inst Nat Sante Rech Med Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
IL140110A0 (en) * 2000-12-05 2002-02-10 Applied Research Systems Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
KR100857376B1 (ko) 2001-01-29 2008-09-05 라보라토리스 세로노 에스.에이. 심장 질환의 치료 및/또는 예방에 사용되는 ｉｌ-18저해물질
EA005769B1 (ru) 2001-03-08 2005-06-30 Арес Трейдинг С.А. Мутанты интерлейкина-18, их продуцирование и применение
EP1425028B1 (de) 2001-05-16 2009-12-16 Yeda Research And Development Co. Ltd. Verwendung von il-18-hemmern zur behandlung oder prävention von sepsis
US7655616B2 (en) 2001-05-25 2010-02-02 Ares Trading S.A. Use of IL-18 inhibitors for treating head injuries
UA78516C2 (en) 2001-08-10 2007-04-10 Applied Research Systems Use of inhibitors of il-18 for treatment and/or prevention of hypersensitivity disorders, and in particular of delayed-type hypersensitivity
IL164211A0 (en) 2002-03-22 2005-12-18 Applied Research Systems Il-18 inhibitors and peripheral vascular diseases
CA2494981A1 (en) 2002-08-14 2004-03-11 Avidis Sa Production of multimeric fusion proteins using a c4bp scaffold
AU2003284260B2 (en) 2002-10-11 2010-06-03 Zymogenetics, Inc. Production of homotrimeric fusion proteins
PL377731A1 (pl) * 2002-12-23 2006-02-06 Bristol-Myers Squibb Company Sposoby hodowli komórek ssaczych do wytwarzania białka
ES2309508T3 (es) 2003-03-11 2008-12-16 Laboratoires Serono Sa Vectores de expresion que comprenden el promotor de mcmv-ie2.
PT1622939E (pt) 2003-05-13 2012-03-28 Merck Serono Sa Variantes ativas da proteína de ligação à il-18 e suas utilizações médicas
CA2541523A1 (en) 2003-10-21 2005-05-06 Applied Research Systems Ars Holding N.V. Minimal dna sequence acting as a chromatin insulator and its use in protein expression
ME01198B (me) 2003-11-05 2013-03-20 Ares Trading Sa Prečišćavanje il-18 vezujućeg proteina
AU2005217154B2 (en) 2004-03-01 2010-02-18 Ares Trading S.A. Use of a serum-free cell culture medium for the production of IL-18BP in mammalian cells
AU2005259269B2 (en) * 2004-06-29 2010-12-09 Ares Trading S.A. Process for the purification of IL-18 binding protein
RS52273B (en) 2005-06-10 2012-10-31 Ares Trading S.A. PROCESS FOR PURIFICATION OF IL-18 BINDING PROTEIN

Also Published As

Publication number Publication date
AU2006254103B2 (en) 2012-09-06
CA2609060A1 (en) 2006-12-07
SI1885753T1 (sl) 2011-12-30
EP2267024A1 (de) 2010-12-29
AU2006254103A1 (en) 2006-12-07
US7691611B2 (en) 2010-04-06
DK2267024T3 (da) 2012-06-25
ES2385639T3 (es) 2012-07-27
NO342802B1 (no) 2018-08-06
PT2267024E (pt) 2012-06-01
CY1113056T1 (el) 2016-04-13
CA2609060C (en) 2014-07-15
ATE557038T1 (de) 2012-05-15
IL187838A0 (en) 2008-03-20
JP2008541748A (ja) 2008-11-27
JP5199073B2 (ja) 2013-05-15
PT1885753E (pt) 2011-10-06
NO20076672L (no) 2008-02-22
DK1885753T3 (da) 2011-10-03
PL2267024T3 (pl) 2012-10-31
CY1111969T1 (el) 2015-11-04
JP5837476B2 (ja) 2015-12-24
SI2267024T1 (sl) 2012-09-28
US20080199913A1 (en) 2008-08-21
PL1885753T3 (pl) 2011-12-30
US20100137195A1 (en) 2010-06-03
EP1885753A1 (de) 2008-02-13
IL187838A (en) 2011-07-31
WO2006128908A1 (en) 2006-12-07
JP2013048633A (ja) 2013-03-14
EP2267024B1 (de) 2012-05-09
ES2370417T3 (es) 2011-12-15
EP1885753B1 (de) 2011-07-27

Similar Documents

Publication Publication Date Title
ATE517917T1 (de) Herstellung eines rekombinanten il-18-bindenden proteins
HK1120052A1 (en) Process for the preparation of glycosylated interferon beta
DE602007011171D1 (de) Zusammensetzung und Verfahren zur Herstellung von Steviolglykosiden
DK1912673T3 (da) Fremgangsmåde til at binde effektor-molekyler til proteiner
CY1116285T1 (el) Ανασυνδυασμενες ν-γλυκοζυλιωμενες πρωτεϊνες απο προκαρυωτικα κυτταρα
SG170116A1 (en) Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
NO20070687L (no) Ny karbamylert EPO og fremgangsmate for deres fremstilling
CR10082A (es) Anticuerpos dirigidos a her-3 y usos de los mismos
DE602006010132D1 (de) Zwischenprodukte für die Herstellung von Trans-5-Chlor-2-Methyl-2,3,3a,12b-Tetrahydro-1h-DibenzÄ2,3:6,7ÜOxepinoÄ4,5-cÜPyrrol
WO2007112082A3 (en) Methods and compositions for the identification of cancer markers
EP1811027A4 (de) Polynukleotid zur herstellung von rekombinantem protein durch seidenraupen
WO2006042745A3 (de) Chemisch modifizierte iapp - peptidanaloga
ATE496913T1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
CY1112312T1 (el) Διεργασια για τον καθαρισμο της πρωτεϊνης δεσμευσης της ιl-18
NO20082989L (no) Fremstiling av gamma-aminosyrer som har affinitet for alfa-2-deltaproteinet
WO2009025300A1 (ja) イミュノグロブリン結合能を有するペプチド
DE602006021355D1 (de) Ein Verfahren zur Herstellung von Tolterodin
HK1119188A1 (en) Recombinant production of heparin binding proteins
WO2008046232A8 (en) Aziridine aldehydes, aziridine-conjugated amino derivatives, aziridine-conjugated biomolecules and processes for their preparation
EP2261243A3 (de) Polypeptidgerüst auf Basis von einer Hemopexin-ähnlichen Struktur
WO2007054970A3 (en) Novel polymorphic forms of (s)-(-)-2-amino-6-(n- propylamino) 4,5,6,7- tetrahydrobenzothiazole
DE602006009439D1 (de) Wanderbettverfahrenverfahren zur Herstellung von Phenylalkanen
EP1799234A4 (de) Verbesserung der rekombinanten hämoglobin-produktion durch koexpression mit alpha-hämoglobin stabilisierendem protein
DE602004002692D1 (de) Verfahren zur Herstellung von Topiramate
EP1935981A4 (de) Verfahren zur herstellung von rekombinantem protein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1885753

Country of ref document: EP